On March 19, 2025, Akebia Therapeutics announced a public offering of 25 million shares at $2.00 each, expecting to raise about $46.5 million, with a potential total of $53.6 million if additional shares are purchased. The offering is set to close on March 21, 2025, pending customary conditions.